Single-Crystal X-ray Diffraction

  • Andrew D. BondEmail author
Part of the Advances in Delivery Science and Technology book series (ADST)


Single-crystal X-ray diffraction is an extremely powerful technique to characterize small drug molecules in solid form. It is a mature technique that is becoming ever more automated, and it is increasingly viewed as “routine” in both industry and academia. On this basis, it is arguable how much the average formulation scientist needs to know about the technique: is it necessary to understand the inner workings of the “black box”, or is it sufficient just to trust the results produced by an automated analysis system? This chapter provides a brief outline of the principles, then considers some aspects that, in the author’s opinion, should still be understood to measure crystallographic data effectively and to interpret crystallographic results. The focus is on selected topics that are likely to be most relevant to pharmaceutical solid-form characterization.


Diffraction X-ray Single-crystal SXRD Absolute structure 


  1. Allen FH (1986) A systematic pairwise comparison of geometric parameters obtained by X-ray and neutron diffraction. Acta Cryst B42:515–522CrossRefGoogle Scholar
  2. Blake AJ, Cole JM, Evans JSO, Main P, Parsons S, Watkin DJ, Clegg W (2009) Crystal structure analysis: principles and practice. Oxford University Press, New YorkGoogle Scholar
  3. Clegg W (1998) Crystal structure determination. Oxford University Press, New YorkGoogle Scholar
  4. Flack HD, Bernardinelli G (2000) Reporting and evaluating absolute-structure and absolute-configuration determinations. J Appl Cryst 33:1143–1148CrossRefGoogle Scholar
  5. Grobelny P, Mukherjee A, Desiraju GR (2011) Drug-drug co-crystals: temperature-dependent proton mobility in the molecular complex of isoniazid with 4-aminosalicylic acid. CrystEngComm 13:4358–4364CrossRefGoogle Scholar
  6. IUCr (2014) checkCIF. Accessed 4 June 2016
  7. Müller P, Herbst-Irmer R, Spek AL, Scheider TR, Sawaya MR (2006) Crystal structure refinement: a crystallographer’s guide to SHELXL. Oxford University Press, New YorkCrossRefGoogle Scholar
  8. Parsons S, Flack HD, Wagner T (2013) Use of intensity quotients and differences in absolute structure refinement. Acta Cryst B69:249–259Google Scholar
  9. Spek AL (2013) Structure validation in chemical crystallography. Acta Cryst D65:148–155Google Scholar
  10. Thompson AL, Watkin DJ (2009) X-ray crystallography and chirality: understanding the limitations. Tetrahedron: Asymmetry 20:712–717CrossRefGoogle Scholar
  11. Van der Sluis P, Spek AL (1990) BYPASS: an effective method for the refinement of crystal structures containing disordered solvent regions. Acta Cryst A46:194–201CrossRefGoogle Scholar
  12. Vega D, Petragalli A, Fernández D, Ellena JA (2006) Polymorphism on leflunomide: stability and crystal structures. J Pharm Sci 95:1075–1083CrossRefPubMedGoogle Scholar

Copyright information

© Controlled Release Society 2016

Authors and Affiliations

  1. 1.Department of ChemistryUniversity of CambridgeCambridgeUK

Personalised recommendations